Methods of treatment using anti-erbb antibody-maytansinoid conjugates
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
Jan 10, 2012
Issued Date -
N/A
app pub date -
Dec 3, 2007
filing date -
Dec 3, 2007
priority date (Note) -
Withdrawn
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
The application concerns methods of treatment using anti-ErbB receptor antibody-maytansinoid conjugates, and articles of manufacture suitable for use in such methods. In particular, the invention concerns ErbB receptor-directed cancer therapies, using anri-ErbB receptor antibody-maytansinoid conjugates.
Loading the Abstract Image...
OK
First Claim
Family
Loading Family data...
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully